Isolation and Structure Elucidation of Chlorofusin, a Novel p53-MDM2 Antagonist from a Fusarium sp.
- 1 January 2001
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 123 (4), 554-560
- https://doi.org/10.1021/ja002940p
Abstract
Wild-type p53 plays a crucial role in the prevention of cancer. Since dysfunction of p53 can be caused by increased levels of the protein MDM2, small molecules which antagonize the interaction between these two proteins have potential in cancer therapy. The discovery and structure determination of a fungal metabolite, chlorofusin, which antagonizes the p53/MDM2 interaction are reported.Keywords
This publication has 9 references indexed in Scilit:
- Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cellsOncogene, 1998
- One-Dimensional NOE Experiments Using Pulsed Field GradientsJournal of Magnetic Resonance, 1997
- Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation DomainScience, 1996
- Biochemical properties and biological effects of p53Current Opinion in Genetics & Development, 1995
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- The p53 tumour suppressor geneNature, 1991
- Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line.The EMBO Journal, 1991
- NMR with Proteins and Nucleic AcidsEurophysics News, 1986
- The beta bulge: a common small unit of nonrepetitive protein structure.Proceedings of the National Academy of Sciences, 1978